Wealth Enhancement Advisory Services LLC Has $5.64 Million Stock Position in Amdocs Limited (NASDAQ:DOX)

Wealth Enhancement Advisory Services LLC increased its stake in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 1.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,367 shares of the technology company’s stock after buying an additional 1,036 shares during the period. Wealth Enhancement Advisory Services LLC owned 0.05% of Amdocs worth $5,636,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DOX. Bahl & Gaynor Inc. raised its position in shares of Amdocs by 2.6% during the fourth quarter. Bahl & Gaynor Inc. now owns 377,316 shares of the technology company’s stock worth $33,162,000 after purchasing an additional 9,436 shares during the period. New York State Teachers Retirement System acquired a new position in shares of Amdocs during the fourth quarter worth approximately $930,000. Royal London Asset Management Ltd. raised its position in shares of Amdocs by 1.9% during the fourth quarter. Royal London Asset Management Ltd. now owns 64,632 shares of the technology company’s stock worth $5,681,000 after purchasing an additional 1,217 shares during the period. Running Oak Capital LLC raised its position in shares of Amdocs by 15.0% during the first quarter. Running Oak Capital LLC now owns 108,734 shares of the technology company’s stock worth $9,826,000 after purchasing an additional 14,205 shares during the period. Finally, Stifel Financial Corp raised its position in shares of Amdocs by 2.7% during the fourth quarter. Stifel Financial Corp now owns 950,353 shares of the technology company’s stock worth $83,526,000 after purchasing an additional 25,300 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of NASDAQ DOX opened at $78.67 on Tuesday. The stock has a market cap of $9.25 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 1.39 and a beta of 0.74. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $98.84. The stock’s 50-day moving average is $80.39 and its 200 day moving average is $86.59.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The technology company reported $1.38 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.05). The firm had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.25 billion. Amdocs had a net margin of 10.62% and a return on equity of 17.85%. On average, sell-side analysts anticipate that Amdocs Limited will post 5.72 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.479 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.92 dividend on an annualized basis and a yield of 2.44%. Amdocs’s dividend payout ratio (DPR) is currently 43.15%.

Analyst Ratings Changes

A number of research firms recently commented on DOX. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Robert W. Baird lowered their price target on Amdocs from $97.00 to $90.00 and set a “neutral” rating for the company in a research report on Thursday, May 9th. Finally, Citigroup lowered their price target on Amdocs from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.80.

Check Out Our Latest Analysis on DOX

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.